Form4insider filings, from the source

SEC Form 4 · accession 0001225208-17-014806

Edwards Lifesciences Corp · EW

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael A Mussallem
Officer — Chairman & CEO · Director
Period of report
Sep 7, 2017
Accepted (ET)
Sep 11, 2017 · 4:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099800

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Sep 7, 2017M32,900$44.615A74,231D
Common StockF3,F2Sep 7, 2017S32,900$112.4481D41,331D
Common StockF4holding———123,931I401(k)
Common StockF2holding———698,095IBy Living Trust

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (Right to Acquire)F2$44.615Sep 7, 2017M32,900DJun 12, 2011May 11, 2018Common Stock32,900249,600D

Explanation of responses